X Q Yu Selected Research

X Q Yu Research Topics

2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 07/2016
2	Peritonitis 03/2016 - 05/2008
1	IGA Glomerulonephritis (IGA Nephropathy) 04/2024
1	Allergic Rhinitis 02/2022
1	Echinococcosis (Hydatid Cysts) 02/2022
1	Diabetes Mellitus 11/2021
1	Hyperkalemia 11/2021
1	Sepsis (Septicemia) 08/2020
1	Acute Kidney Injury (Acute Renal Failure) 08/2020
1	Pneumonia (Pneumonitis) 05/2019
1	Infections 09/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2017
1	Periodontal Diseases (Periodontal Disease) 01/2017
1	Alveolar Bone Loss 01/2017
1	Neoplasms (Cancer) 01/2017
1	Hypoxia (Hypoxemia) 07/2016
1	Abdominal Aortic Aneurysm 05/2016
1	Endoleak 05/2016
1	Rectal Fistula (Anal Fistula) 05/2013
1	Fistula 05/2013
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2013
1	Conversion Disorder (Astasia Abasia) 11/2009
1	Lupus Nephritis 07/2008
1	Fibrosis (Cirrhosis) 12/2007
1	Peritoneal Fibrosis 12/2007
1	Gram-Negative Bacterial Infections 12/2000
1	Kidney Diseases (Kidney Disease) 10/2000
1	Glomerulonephritis 02/2000

2	Proteins (Proteins, Gene)FDA Link 02/2022 - 07/2016
1	OvalbuminIBA 02/2022
1	Bicarbonates (Hydrogen Carbonate)IBA 11/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2021
1	Phosphorus (Red Phosphorus)IBA 11/2021
1	CreatinineIBA 11/2021
1	AngiotensinsIBA 11/2021
1	Triglycerides (Triacylglycerol)IBA 11/2021
1	Serum AlbuminIBA 11/2021
1	CytokinesIBA 08/2020
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 08/2020
1	salicylhydroxamic acid (SHAM)IBA 08/2020
1	gremubamabIBA 05/2019
1	AntibodiesIBA 09/2018
1	Recombinant ProteinsIBA 09/2018
1	EpitopesIBA 09/2018
1	Interleukin-27 (Interleukin 27)IBA 07/2017
1	Sorafenib (BAY 43-9006)FDA Link 07/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Messenger RNA (mRNA)IBA 07/2016
1	Annexin A5IBA 07/2016
1	CAY10566IBA 07/2016
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 07/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2016
1	Virulence Factors (Pathogenicity Factors)IBA 03/2016
1	Capsules (Microcapsules)IBA 03/2016
1	Indicators and Reagents (Reagents)IBA 03/2013
1	LithiumIBA 11/2009
1	PowdersIBA 11/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2008
1	Leflunomide (Arava)FDA LinkGeneric 07/2008
1	Prednisone (Sone)FDA LinkGeneric 07/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2007
1	Pattern Recognition ReceptorsIBA 12/2000
1	OsteopontinIBA 10/2000
1	Macrophage Migration-Inhibitory FactorsIBA 02/2000

3	Peritoneal Dialysis 11/2021 - 12/2007
3	Ligation 08/2020 - 05/2013
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 03/2016 - 05/2008
1	Genomic Medicine 04/2024
1	Renal Dialysis (Hemodialysis) 11/2021
1	Punctures 08/2020
1	Laparotomy 08/2020
1	Critical Care (Surgical Intensive Care) 01/2017
1	Stents 05/2016
1	Length of Stay 05/2016
1	Operative Time 05/2013
1	Electrodes (Electrode) 11/2009
1	Lasers (Laser) 11/2009
1	Therapeutics 07/2008
1	Microbubbles 12/2007